Clinical Trial

Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/or Viral Tonsillitis

Study acronym: PharyTol
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to conduct post-marketing clinical follow-up of four products: HMG, PHN, PHR, and TUR. This follow-up will consist of collecting clinical data in real-life conditions to confirm the tolerance, safety, and efficacy of medical devices used in the treatment of sore throats related to acute pharyngitis and/or viral-origin tonsillitis, while also assessing the benefit/risk ratio of the products.
Protocol Amendment History 1 change
critical Recruitment opened 2026-08-06
Trial Details
NCT Number NCT07569939
Lead Sponsor University Hospital, Clermont-Ferrand
Conditions Acute Pharyngitis, Viral Sore Throat
Enrollment 160 participants
Start Date 2026-07-29
Primary Completion 2028-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-05